Neovasc Inc (NVCN) SEC Filing 6-K Foreign Issuer Report for the period ending Thursday, May 12, 2022

Neovasc Inc

CIK: 1399708 Ticker: NVCN

View differences made from one to another to evaluate Neovasc Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Neovasc Inc.


Assess how Neovasc Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Neovasc Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Material Contracts, Statements, Certifications & more

Neovasc Inc provided additional information to their SEC Filing as exhibits

Ticker: NVCN
CIK: 1399708
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001062993-22-012302
Submitted to the SEC: Thu May 12 2022 6:53:03 PM EST
Accepted by the SEC: Fri May 13 2022
Period: Thursday, May 12, 2022
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: